{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T08:06:07Z","timestamp":1790755567024,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100008986","name":"University of Guelph","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008986","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychoneuroendocrinology"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.psyneuen.2019.104413","type":"journal-article","created":{"date-parts":[[2019,8,26]],"date-time":"2019-08-26T11:25:31Z","timestamp":1566818731000},"page":"104413","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Female mice are protected against acute olanzapine-induced hyperglycemia"],"prefix":"10.1016","volume":"110","author":[{"given":"Kyle D.","family":"Medak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Logan K.","family":"Townsend","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret K.","family":"Hahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.psyneuen.2019.104413_bib0005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0022662","article-title":"A double blind, placebo-controlled, randomized crossover study of the acute metabolic effects of olanzapine in healthy volunteers","volume":"6","author":"Albaugh","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.psyneuen.2019.104413_bib0010","article-title":"Antipsychotic-induced weight gain: a review of the literature","author":"Allison","year":"2001","journal-title":"J. Clin. Psychiatry"},{"issue":"6","key":"10.1016\/j.psyneuen.2019.104413_bib0015","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1503\/jpn.110140","article-title":"Differential effects of 3 classes of antidiabetic drugs on olanzapine-induced glucose dysregulation and insulin resistance in female rats","volume":"37","author":"Boyda","year":"2012","journal-title":"J. Psychiatry Neurosci.: JPN"},{"issue":"6","key":"10.1016\/j.psyneuen.2019.104413_bib0020","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.pnpbp.2010.04.024","article-title":"A parametric study of the acute effects of antipsychotic drugs on glucose sensitivity in an animal model","volume":"34","author":"Boyda","year":"2010","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2019.104413_bib0025","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.psyneuen.2017.05.005","article-title":"Glucagon receptor knockout mice are protected against acute olanzapine-induced hyperglycemia","volume":"82","author":"Castellani","year":"2017","journal-title":"Psychoneuroendocrinology"},{"issue":"1\u20133","key":"10.1016\/j.psyneuen.2019.104413_bib0030","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.schres.2008.12.012","article-title":"Insulin resistance and secretion in vivo: effects of different antipsychotics in an animal model","volume":"108","author":"Chintoh","year":"2009","journal-title":"Schizophr. Res."},{"issue":"5","key":"10.1016\/j.psyneuen.2019.104413_bib0035","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1097\/JCP.0b013e318184b4c5","article-title":"Insulin resistance and decreased glucose-stimulated insulin secretion after acute olanzapine administration","volume":"28","author":"Chintoh","year":"2008","journal-title":"J. Clin. Psychopharmacol."},{"issue":"6","key":"10.1016\/j.psyneuen.2019.104413_bib0040","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1097\/JCP.0b013e3181bfe13e","article-title":"30 days of continuous olanzapine infusion determines energy imbalance, glucose intolerance, insulin resistance, and dyslipidemia in mice","volume":"29","author":"Coccurello","year":"2009","journal-title":"J. Clin. Psychopharmacol."},{"issue":"9","key":"10.1016\/j.psyneuen.2019.104413_bib0045","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0149-2918(00)80086-7","article-title":"The effects of olanzapine, risperidone, and haloperidol on plasma prolactin levels in patients with schizophrenia","volume":"22","author":"David","year":"2000","journal-title":"Clin. Ther."},{"issue":"9","key":"10.1016\/j.psyneuen.2019.104413_bib0050","doi-asserted-by":"crossref","first-page":"981","DOI":"10.2217\/pgs.15.55","article-title":"Metabolic side effects and pharmacogenetics of second-generation antipsychotics in children","volume":"16","author":"Devlin","year":"2015","journal-title":"Pharmacogenomics"},{"issue":"22","key":"10.1016\/j.psyneuen.2019.104413_bib0055","doi-asserted-by":"crossref","first-page":"12737","DOI":"10.1073\/pnas.96.22.12737","article-title":"Sterol regulatory element binding protein-1c is a major mediator of insulin action on the hepatic expression of glucokinase and lipogenesis-related genes","volume":"96","author":"Foretz","year":"1999","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"6","key":"10.1016\/j.psyneuen.2019.104413_bib0060","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.jpsychires.2008.11.001","article-title":"Antipsychotic-induced body weight gain: predictors and a systematic categorization of the long-term weight course","volume":"43","author":"Gebhardt","year":"2009","journal-title":"J. Psychiatr. Res."},{"issue":"9","key":"10.1016\/j.psyneuen.2019.104413_bib0065","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1001\/jamapsychiatry.2015.0891","article-title":"Evaluation of antipsychotic dose reduction in late-life schizophrenia: a prospective dopamine D2\/3 receptor occupancy study","volume":"72","author":"Graff-Guerrero","year":"2015","journal-title":"JAMA Psychiatry"},{"issue":"4","key":"10.1016\/j.psyneuen.2019.104413_bib0070","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.cmet.2015.07.027","article-title":"Hepatic mitochondrial pyruvate carrier 1 is required for efficient regulation of gluconeogenesis and whole-body glucose homeostasis","volume":"22","author":"Gray","year":"2015","journal-title":"Cell Metab."},{"issue":"1\u20133","key":"10.1016\/j.psyneuen.2019.104413_bib0075","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.schres.2011.06.004","article-title":"Atypical antipsychotics and effects of muscarinic, serotonergic, dopaminergic and histaminergic receptor binding on insulin secretion in vivo: an animal model","volume":"131","author":"Hahn","year":"2011","journal-title":"Schizophr. Res."},{"issue":"3","key":"10.1016\/j.psyneuen.2019.104413_bib0080","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.euroneuro.2013.07.011","article-title":"Effects of intracerebroventricular (ICV) olanzapine on insulin sensitivity and secretion in vivo: an animal model","volume":"24","author":"Hahn","year":"2014","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"6","key":"10.1016\/j.psyneuen.2019.104413_bib0085","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1097\/JCP.0b013e31829e8333","article-title":"Acute effects of single-dose olanzapine on metabolic, endocrine, and inflammatory markers in healthy controls","volume":"33","author":"Hahn","year":"2013","journal-title":"J. Clin. Psychopharmacol."},{"issue":"7","key":"10.1016\/j.psyneuen.2019.104413_bib0090","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.98569","article-title":"17-\u03b2 Estradiol regulates proglucagon-derived peptide secretion in mouse and human \u03b1-and L cells","volume":"3","author":"Handgraaf","year":"2018","journal-title":"JCI Insight"},{"issue":"2","key":"10.1016\/j.psyneuen.2019.104413_bib0095","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/sj.npp.1301209","article-title":"Acute effects of atypical antipsychotics on whole-body insulin resistance in rats: implications for adverse metabolic effects","volume":"32","author":"Houseknecht","year":"2007","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.psyneuen.2019.104413_bib0100","doi-asserted-by":"crossref","first-page":"39","DOI":"10.4103\/0019-5545.31617","article-title":"Weight gain with olanzapine: Drug, gender or age?","volume":"48","author":"Jain","year":"2006","journal-title":"Indian J. Psychiatry"},{"issue":"3","key":"10.1016\/j.psyneuen.2019.104413_bib0105","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s00213-011-2397-y","article-title":"Acute effects of orexigenic antipsychotic drugs on lipid and carbohydrate metabolism in rat","volume":"219","author":"Jassim","year":"2012","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.psyneuen.2019.104413_bib0110","doi-asserted-by":"crossref","first-page":"10856","DOI":"10.1038\/ncomms10856","article-title":"AMPK antagonizes hepatic glucagon-stimulated cyclic AMP signalling via phosphorylation-induced activation of cyclic nucleotide phosphodiesterase 4B","volume":"7","author":"Johanns","year":"2016","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.psyneuen.2019.104413_bib0115","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1124\/jpet.102.046987","article-title":"Antipsychotic dosing in preclinical models is often unrepresentative of the clinical condition: a suggested solution based on in vivo occupancy","volume":"305","author":"Kapur","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"2","key":"10.1016\/j.psyneuen.2019.104413_bib0120","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1093\/schbul\/sbs196","article-title":"Second-generation antipsychotics cause a rapid switch to fat oxidation that is required for survival in C57BL\/6J mice","volume":"40","author":"Klingerman","year":"2013","journal-title":"Schizophr. Bull."},{"issue":"4","key":"10.1016\/j.psyneuen.2019.104413_bib0125","doi-asserted-by":"crossref","first-page":"803","DOI":"10.2337\/db08-1054","article-title":"Sex and depot differences in adipocyte insulin sensitivity and glucose metabolism","volume":"58","author":"Macotela","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.psyneuen.2019.104413_bib0130","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.molmet.2018.05.008","article-title":"Sex differences in lipid and lipoprotein metabolism","volume":"15","author":"Palmisano","year":"2018","journal-title":"Mol. Metab."},{"key":"10.1016\/j.psyneuen.2019.104413_bib0135","series-title":"Regulation of Hepatic Follistatin Expression at Rest and During Exercise in Mice. Medicine and Science in Sports and Exercise","author":"Peppler","year":"2019"},{"issue":"1","key":"10.1016\/j.psyneuen.2019.104413_bib0140","first-page":"23","article-title":"Table of nonprotein respiratory quotient: an update","volume":"16","author":"Peronnet","year":"1991","journal-title":"Can. J. Sport Sci."},{"issue":"3","key":"10.1016\/j.psyneuen.2019.104413_bib0145","doi-asserted-by":"crossref","first-page":"G619","DOI":"10.1152\/ajpgi.00428.2007","article-title":"Daily exercise increases hepatic fatty acid oxidation and prevents steatosis in Otsuka Long-Evans Tokushima Fatty rats","volume":"294","author":"Rector","year":"2008","journal-title":"Am. J. Physiol. Gastrointestinal Liver Physiol."},{"key":"10.1016\/j.psyneuen.2019.104413_bib0150","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.phrs.2015.07.022","article-title":"Metabolic syndrome and obesity among users of second generation antipsychotics: a global challenge for modern psychopharmacology","volume":"101","author":"Rojo","year":"2015","journal-title":"Pharmacol. Res."},{"issue":"2","key":"10.1016\/j.psyneuen.2019.104413_bib0155","first-page":"R315","article-title":"Prior exercise training blunts short-term high-fat diet-induced weight gain","volume":"311","author":"Snook","year":"2016","journal-title":"Am. J. Physiol. Gastrointestinal Liver Physiol."},{"issue":"3","key":"10.1016\/j.psyneuen.2019.104413_bib0160","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.eurpsy.2009.01.001","article-title":"How can antipsychotics cause diabetes mellitus? Insights based on receptor-binding profiles, humoral factors and transporter proteins","volume":"24","author":"Starrenburg","year":"2009","journal-title":"Eur. Psychiatry"},{"issue":"11","key":"10.1016\/j.psyneuen.2019.104413_bib0165","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1073\/pnas.81.11.3317","article-title":"Hormonal regulation of hormone-sensitive lipase in intact adipocytes: identification of phosphorylated sites and effects on the phosphorylation by lipolytic hormones and insulin","volume":"81","author":"Str\u00e5lfors","year":"1984","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"7","key":"10.1016\/j.psyneuen.2019.104413_bib0170","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1007\/s00394-011-0266-4","article-title":"Estrogen modulates abdominal adiposity and protects female mice from obesity and impaired glucose tolerance","volume":"51","author":"Stubbins","year":"2012","journal-title":"Eur. J. Nutr."},{"key":"10.1016\/j.psyneuen.2019.104413_bib0175","doi-asserted-by":"crossref","DOI":"10.1096\/fj.201802048RR","article-title":"Loss of glucagon signaling alters white adipose tissue browning","author":"Townsend","year":"2019","journal-title":"Faseb J."},{"key":"10.1016\/j.psyneuen.2019.104413_bib0180","doi-asserted-by":"crossref","DOI":"10.1194\/jlr.M092510","article-title":"High saturated fat diet-induced obesity causes hepatic Interleukin-6 resistance via endoplasmic reticulum stress","author":"Townsend","year":"2019","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.psyneuen.2019.104413_bib0185","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.psyneuen.2017.12.004","article-title":"Obesity exacerbates the acute metabolic side effects of olanzapine","volume":"88","author":"Townsend","year":"2018","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.psyneuen.2019.104413_bib0190","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3389\/fendo.2014.00241","article-title":"Sex-specific differences in lipid and glucose metabolism","volume":"5","author":"Varlamov","year":"2015","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"6852","key":"10.1016\/j.psyneuen.2019.104413_bib0195","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/35093050","article-title":"Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1","volume":"413","author":"Yoon","year":"2001","journal-title":"Nature"}],"container-title":["Psychoneuroendocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306453019306146?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306453019306146?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T17:06:43Z","timestamp":1759684003000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306453019306146"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":39,"alternative-id":["S0306453019306146"],"URL":"https:\/\/doi.org\/10.1016\/j.psyneuen.2019.104413","relation":{},"ISSN":["0306-4530"],"issn-type":[{"value":"0306-4530","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Female mice are protected against acute olanzapine-induced hyperglycemia","name":"articletitle","label":"Article Title"},{"value":"Psychoneuroendocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psyneuen.2019.104413","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104413"}}